 Live video webcast on Tuesday, January 17th at 10:00 AM ET FRAMINGHAM, MA ACCESSWIRE January 5, 2023 Xenetic Biosciences, Inc. NASDAQ:XBIO Xenetic or the Company, a biopharmaceutical company focused on advancing innovative immune-oncology technologies addressing hard to treat oncology indications, today announced that Jeffrey Eisenberg, Chief Executive Officer of Xenetic Biosciences will present at the Virtual Investor 2023 Companies to Watch Event on Tuesday, January 17, 2023 at 10:00 AM ET. A live video webcast of the presentation will be available on the Events page in the Investors section of the Companys website 